87 related articles for article (PubMed ID: 26526)
41. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
Avramis VI; Powell W
Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
[TBL] [Abstract][Full Text] [Related]
42. Uridine kinase activities in normal and neoplastic lymphoid cells.
Greenberg N; Schumm DE; Hurtubise PE; Webb TE
Cancer Res; 1977 Apr; 37(4):1028-34. PubMed ID: 66093
[TBL] [Abstract][Full Text] [Related]
43. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
Klubes P; Cerna I
Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
[TBL] [Abstract][Full Text] [Related]
44. Cell cycle arrest as a basis of enhancement of 1-beta-D-arabinofuranosylcytosine anabolism in human lymphoblastoid RPMI 6410 cells cultured with 3-deazauridine.
Lauzon GJ; Yang S; Paterson AR
Biochem Pharmacol; 1981 Jul; 30(14):1889-94. PubMed ID: 6895033
[No Abstract] [Full Text] [Related]
45. Some properties of uridine-cytidine kinase from a human malignant lymphoma.
Ahmed NK; Welch AD
Cancer Res; 1979 Aug; 39(8):3102-6. PubMed ID: 36981
[No Abstract] [Full Text] [Related]
46. Pharmokinetics of 2'-deoxycoformycin in normal and L1210 leukemic mice.
McConnell WR; Furner RL; Hill DL
Drug Metab Dispos; 1979; 7(1):11-3. PubMed ID: 35319
[TBL] [Abstract][Full Text] [Related]
47. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
Moyer JD; Handschumacher RE
Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
[No Abstract] [Full Text] [Related]
48. Distribution of tetraphenylporphinesulfonate and tetracarboxyphenylporphine in tumor-bearing mice.
Musser DA; Wagner JM; Datta-Gupta N
J Natl Cancer Inst; 1978 Dec; 61(6):1397-403. PubMed ID: 281547
[No Abstract] [Full Text] [Related]
49. Pharmacokinetic considerations in evaluating the effects of tetrahydrouridine on 5-azacytidine chemotherapy in L1210 leukemic mice.
Kelly CJ; Gaudio L; Yesair DW; Schoenemann PT; Wodinsky I
Cancer Treat Rep; 1978 Jul; 62(7):1025-32. PubMed ID: 80268
[TBL] [Abstract][Full Text] [Related]
50. Galactosyltransferase activity and cell growth: uridine diphosphate (UDP)galactose inhibition of murine leukemic L1210 cells.
Klohs WD; Wilson JR; Weiser MM; Frankfurt O; Bernacki RJ
J Cell Physiol; 1984 Apr; 119(1):23-8. PubMed ID: 6423650
[TBL] [Abstract][Full Text] [Related]
51. Uridine kinase: properties, biological significance and chemotherapeutic aspects (a review).
Cihák A; Rada B
Neoplasma; 1976; 23(3):233-57. PubMed ID: 60713
[No Abstract] [Full Text] [Related]
52. Biochemical characterization of fluoropyrimidine-resistant murine leukemic cell lines.
Mulkins MA; Heidelberger C
Cancer Res; 1982 Mar; 42(3):965-73. PubMed ID: 7059992
[TBL] [Abstract][Full Text] [Related]
53. Tissue uridine pools: evidence in vivo of a concentrative mechanism for uridine uptake.
Darnowski JW; Handschumacher RE
Cancer Res; 1986 Jul; 46(7):3490-4. PubMed ID: 3708581
[TBL] [Abstract][Full Text] [Related]
54. Cytotoxicity of a new uridine analog, 4-hydroxy-1-(beta-D-ribofuranosyl)-pyridazine-6-one, and its interaction with uridine kinase.
Bloomer LC; Wotring LL; Townsend LB
Cancer Res; 1982 Jan; 42(1):100-6. PubMed ID: 6172193
[TBL] [Abstract][Full Text] [Related]
55. [Effect of chemotherapy on the nucleoside phosphate kinase activity in experimental tumors].
Tret'iakov AV; Filov VA
Vopr Onkol; 1986; 32(11):95-8. PubMed ID: 3024413
[TBL] [Abstract][Full Text] [Related]
56. Uridine-cytidine kinase. IV. Kinetics of the competition between 5-azacytidine and the two natural substrates.
Liacouras AS; Anderson EP
Mol Pharmacol; 1979 Mar; 15(2):331-40. PubMed ID: 89627
[No Abstract] [Full Text] [Related]
57. Some determinants of camptothecin responsiveness in leukemia L1210 cells.
Kessel D
Cancer Res; 1971 Dec; 31(12):1883-7. PubMed ID: 5120286
[No Abstract] [Full Text] [Related]
58. The effects of nucleoside analogs on cutaneous neoplasms.
Klein E; Burgess GH; Bloch A; Milgrom H; Holtermann OA
Ann N Y Acad Sci; 1975 Aug; 255():216-24. PubMed ID: 1059357
[No Abstract] [Full Text] [Related]
59. Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole.
Brockman RW; Shaddix S; Laster WR; Schabel FM
Cancer Res; 1970 Sep; 30(9):2358-68. PubMed ID: 5475481
[No Abstract] [Full Text] [Related]
60. Inhibitory effects of pseudouridinedicarboxaldehyde on tubulin metabolism.
Lewis ML; Clark JA; Miller JF; Bartel AH; Kimball AP
Biochem Pharmacol; 1982 Jan; 31(2):273-6. PubMed ID: 6895849
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
